Event

Moises Selman

MD
Inst Nac De Enfermedades Respiratorias;Instituto Nacional de Enfermedades Respiratorias;Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, CONACYT-INER;Instituto Nacional de Enfer

Daniel Wachtlin

MSc
Boehringer Ingelheim Pharma GmbH & Co. KG

Susanne Stowasser

M.D.
Boehringer Ingelheim Pharma GmbH & Co. KG

Claudia Diefenbach

Senior Translational Medicine Expert
BI Pharma GmbH & Co. KG;Boehringer Ingelheim Pharma GmbH & Co. KG

Toby M. Maher

MD, MSc, PhD, FRCP
Imperial College;Imperial College London;Imperial College, London;National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Hare;Royal Brompton and Harefield NHS

Richard Gisli. Jenkins

BM, MD, MRCP(UK), PhD
City Hospital, University of Nottingham;University of Nottingham

Yasuhiko Nishioka

MD, PhD
Graduate School of Biomedical Sciences, Tokushima University;Tokushima Univ;Tokushima University

Eric S. White

MD, MS
Univ of Michigan;University of Michigan;University of Michigan, Division of Pulmonary & Critical Care Medicine

Vincent Cottin

PhD, MD
Hopital Louis Pradel, Universite de Lyon;Louis Pradel Hosp, Univ of Lyon;Louis Pradel Hospital and Université Claude Bernard Lyon 1;Louis Pradel Hospital, Claude Bernard University Lyon 1

Imre Noth

MD
Pulmonary and Critical Care Medicine, University of Chicago;Univ of Chicago;University of Chicago

Investigating the Effect of Nintedanib on Changes in Biomarkers of ECM Turnover in Patients with IPF and Limited FVC Impairment: Design of the INMARK Study